General
Sickest coronavirus patients to be treated with arthritis drugs after study finds reduction in death rates
A study has found treating critically ill COVID-19 patients with Roche’s Actemra or Sanofi’s Kevzara arthritis drugs significantly improves survival rates and reduces the amount of time patients need intensive care.
Key points:
- The study involved 800 severely ill COVID-19 patients
- The UK Government said the drugs will be used to treat critically ill COVID-19 patients
- Results showed that on average, patients treated with Actemra or Kevzara recovered more swiftly
The findings, which have not yet been peer-reviewed, showed that the immunosuppressive drugs — Actemra, also known as tocilizumab, and Kevzara, also known as sarilumab — reduced death rates by 8.5 percentage points among patients hospitalised and severely ill with the pandemic…
-
Noosa News22 hours agoWas Sir Joh ‘God’, as David Littleproud says, or a template for Trump?
-
Noosa News22 hours agoNRL live updates: Brisbane Broncos vs Cronulla Sutherland Sharks, Sydney Roosters vs North Queensland Cowboys, Parramatta Eels vs Gold Coast Titans
-
General21 hours agoAustralia urges de-escalation as US strikes Iran
-
General20 hours agoAustralian government calls for de-escalation of war in Iran as Coalition endorses US strikes